Key Highlights
- LRCX climbed to a record $275.99, posting a 5.56% single-day gain
- Yearly performance shows an impressive 252% return
- Wall Street analysts have upgraded targets to a range of $310-$340
- SVP Neil Fernandes executed a $4.6M stock sale on May 1 through a pre-arranged 10b5-1 plan
- New U.S. export controls targeting China’s Hua Hong create potential challenges
Shares of Lam Research (LRCX) reached an unprecedented peak of $275.99 during trading on May 5, 2026, climbing more than 5.5% in a single session. This milestone caps off a remarkable twelve-month period that delivered 252% returns to shareholders, elevating the semiconductor equipment manufacturer’s valuation to $343 billion.
Lam Research Corporation, LRCX
Top-line figures demonstrate approximately 27% expansion over the trailing twelve-month period. The firm earns a flawless Piotroski Score of 9, an indicator of robust financial strength monitored by InvestingPro.
The equity currently commands a price-to-earnings multiple of 48.75. According to InvestingPro’s valuation framework, LRCX appears elevated compared to its calculated Fair Value benchmark.
Financial analysts across Wall Street have been revising their projections upward. Following LRCX’s fiscal third-quarter performance that exceeded both internal and market expectations, Stifel elevated its price objective to $325 while maintaining a Buy recommendation.
TD Cowen pushed even higher, setting a $340 target. The firm highlighted LRCX’s expanding market position in foundry and DRAM segments, alongside anticipated expansion in NAND wafer fabrication equipment expenditures.
Cantor Fitzgerald maintained its Overweight stance with a $320 projection. The firm referenced an enhanced outlook for wafer fab equipment throughout calendar 2026, forecasting sector expansion of no less than 27%.
UBS preserved its Buy rating at a $310 target, observing that LRCX is positioned at the beginning of what analysts describe as an artificial intelligence-fueled expansion phase.
Executive Stock Transaction Creates Headlines
Senior Vice President Neil Fernandes divested 18,170 shares on May 1 at $255.14 per share, generating approximately $4.64 million in proceeds. The transaction occurred under a Rule 10b5-1 trading arrangement that Fernandes established on November 17, 2025.
Following this sale, Fernandes maintains direct ownership of 66,129 shares. Additionally, he controls slightly more than 1,015 shares through indirect holdings in a 401(k) retirement account.
Pre-established trading programs of this nature are standard practice for corporate officers and typically don’t signal specific sentiment about future stock performance.
Export Controls Introduce Regulatory Complexity
The picture isn’t entirely without complications. The U.S. Department of Commerce implemented new limitations on semiconductor equipment exports to Hua Hong, China’s number-two chipmaker. Lam Research was included among the American equipment suppliers subject to these constraints.
These restrictions initially triggered a decline across chip equipment stocks when announced. The complete financial ramifications for LRCX stemming from these regulatory measures remain unclear.
Fourth-quarter fiscal projections surpassed analyst expectations. The company is currently achieving profitability and revenue benchmarks that were initially projected for calendar year 2028.
LRCX’s third fiscal quarter performance exceeded both Stifel’s forecasts and broader consensus estimates, catalyzing the recent round of upward analyst revisions.
The stock concluded trading on May 5 at its record level of $275.99.
